STAT3 and neoplasm: Beguelin and associates [57] reported that IL-10 promotes tumor cell proliferation and survival by STAT3 signal pathway, and blocking of IL-10 receptor was suggested as a novel therapeutic target in diffused large B-cell lymphoma [57].